Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

T-cell immunity to Kaposi sarcoma-associated herpesvirus: recognition of primary effusion lymphoma by LANA-specific CD4+ T cells.

Sabbah S, Jagne YJ, Zuo J, de Silva T, Ahasan MM, Brander C, Rowland-Jones S, Flanagan KL, Hislop AD.

Blood. 2012 Mar 1;119(9):2083-92. doi: 10.1182/blood-2011-07-366476.

2.

Primary B Lymphocytes Infected with Kaposi's Sarcoma-Associated Herpesvirus Can Be Expanded In Vitro and Are Recognized by LANA-Specific CD4+ T Cells.

Nicol SM, Sabbah S, Brulois KF, Jung JU, Bell AI, Hislop AD.

J Virol. 2016 Mar 28;90(8):3849-59. doi: 10.1128/JVI.02377-15.

4.

Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.

Gjyshi O, Roy A, Dutta S, Veettil MV, Dutta D, Chandran B.

J Virol. 2015 Aug;89(15):7874-92. doi: 10.1128/JVI.00895-15.

5.

IRF-4-mediated CIITA transcription is blocked by KSHV encoded LANA to inhibit MHC II presentation.

Cai Q, Banerjee S, Cervini A, Lu J, Hislop AD, Dzeng R, Robertson ES.

PLoS Pathog. 2013 Oct;9(10):e1003751. doi: 10.1371/journal.ppat.1003751.

7.
8.

Kaposi's sarcoma-associated herpesvirus-encoded LANA contributes to viral latent replication by activating phosphorylation of survivin.

Lu J, Jha HC, Verma SC, Sun Z, Banerjee S, Dzeng R, Robertson ES.

J Virol. 2014 Apr;88(8):4204-17. doi: 10.1128/JVI.03855-13.

9.
10.

Differences in Kaposi sarcoma-associated herpesvirus-specific and herpesvirus-non-specific immune responses in classic Kaposi sarcoma cases and matched controls in Sicily.

Amodio E, Goedert JJ, Barozzi P, Riva G, Firenze A, Bonura F, Viviano E, Romano N, Luppi M.

Cancer Sci. 2011 Oct;102(10):1769-73. doi: 10.1111/j.1349-7006.2011.02032.x.

11.

Azidothymidine Sensitizes Primary Effusion Lymphoma Cells to Kaposi Sarcoma-Associated Herpesvirus-Specific CD4+ T Cell Control and Inhibits vIRF3 Function.

Williamson SJ, Nicol SM, St├╝rzl M, Sabbah S, Hislop AD.

PLoS Pathog. 2016 Nov 28;12(11):e1006042. doi: 10.1371/journal.ppat.1006042.

12.

Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with human myeloid cell nuclear differentiation antigen induced by interferon alpha.

Fukushi M, Higuchi M, Oie M, Tetsuka T, Kasolo F, Ichiyama K, Yamamoto N, Katano H, Sata T, Fujii M.

Virus Genes. 2003 Dec;27(3):237-47.

PMID:
14618084
13.
14.

KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation.

Hassman LM, Ellison TJ, Kedes DH.

J Clin Invest. 2011 Feb;121(2):752-68. doi: 10.1172/JCI44185.

15.

Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies.

Paul AG, Chandran B, Sharma-Walia N.

Transl Res. 2013 Aug;162(2):77-92. doi: 10.1016/j.trsl.2013.03.004. Review.

PMID:
23567332
16.

Kaposi's sarcoma-associated herpesvirus-encoded LANA can induce chromosomal instability through targeted degradation of the mitotic checkpoint kinase Bub1.

Sun Z, Xiao B, Jha HC, Lu J, Banerjee S, Robertson ES.

J Virol. 2014 Jul;88(13):7367-78. doi: 10.1128/JVI.00554-14.

18.

Identification of Caspase Cleavage Sites in KSHV Latency-Associated Nuclear Antigen and Their Effects on Caspase-Related Host Defense Responses.

Davis DA, Naiman NE, Wang V, Shrestha P, Haque M, Hu D, Anagho HA, Carey RF, Davidoff KS, Yarchoan R.

PLoS Pathog. 2015 Jul 28;11(7):e1005064. doi: 10.1371/journal.ppat.1005064.

20.

Physical and functional interactions between STAT3 and Kaposi's sarcoma-associated herpesvirus-encoded LANA.

Muromoto R, Okabe K, Fujimuro M, Sugiyama K, Yokosawa H, Seya T, Matsuda T.

FEBS Lett. 2006 Jan 9;580(1):93-8.

Items per page

Supplemental Content

Support Center